Cargando…

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension

BACKGROUND: following the publication of SYMPLICITY HTN-3 the field of renal of denervation was put on hold. Although SYMPLICITY HTN-3 was well-designed and sham-controlled trial it failed to show any meaningful reduction in office or 24 h ambulatory blood pressure. The procedure was however safe an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papademetriou, Vasilios, Stavropoulos, Konstantinos, Imprialos, Kostas, Doumas, Michael, Schmieder, Roland E., Pathak, Atul, Tsioufis, Costas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803019/ https://www.ncbi.nlm.nih.gov/pubmed/33447752 http://dx.doi.org/10.1016/j.ijchy.2019.100022

Ejemplares similares

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Renal denervation for uncontrolled hypertension
por: Marcusohn, Erez, et al.
Publicado: (2023)

Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension
por: Doumas, Michael, et al.
Publicado: (2017)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Benefits from Treatment and Control of Patients with Resistant Hypertension
por: Doumas, Michael, et al.
Publicado: (2010)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

Serial changes in vessel walls of renal arteries after catheter-based renal artery denervation: insights from volumetric computed tomography analysis
por: Kataoka, Yu, et al.
Publicado: (2018)

Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data
por: Athyros, Vasilios G., et al.
Publicado: (2020)

Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

Common Secondary Causes of Resistant Hypertension and Rational for Treatment
por: Faselis, Charles, et al.
Publicado: (2011)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Renal Denervation in Hypertensive Patients: Back to Anatomy?
por: Persu, Alexandre, et al.
Publicado: (2020)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH)
por: Moss, Jonathan G., et al.
Publicado: (2016)

Renal denervation: a glimpse of hope?
por: Voskuil, M.
Publicado: (2017)

Initial Experience with Renal Denervation for the Treatment of Resistant Hypertension - The Utility of Novel Anesthetics and Metaiodobenzylguanidine Scintigraphy (MIBG)
por: Ziakas, Antonios, et al.
Publicado: (2016)

Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension
por: Hering, Dagmara, et al.
Publicado: (2022)

Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
por: Tsioufis, Costas, et al.
Publicado: (2011)

Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation
por: Schmieder, Roland E., et al.
Publicado: (2016)

Catheter‐based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension
por: Liu, Senyan, et al.
Publicado: (2022)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Intravascular Renal Denervation in Renal Dialysis Patients with Uncontrolled Hypertension: A Case Series of Four Patients
por: Pietilä-Effati, Päivi M., et al.
Publicado: (2018)

COVID-19: The Waterloo of governments, healthcare systems, and large health organizations
por: Doumas, Michael, et al.
Publicado: (2020)

Renal Denervation for Uncontrolled and Resistant Hypertension: Systematic Review and Network Meta-Analysis of Randomized Trials
por: Silverwatch, Jonathan, et al.
Publicado: (2021)

Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension
por: Dell’Oro, Raffaella, et al.
Publicado: (2023)

Renal Denervation as a Complementary Treatment Option for Uncontrolled Arterial Hypertension: A Situation Assessment
por: Wagener, Max, et al.
Publicado: (2023)

Recent advances in understanding and managing resistant/refractory hypertension
por: Doumas, Michael, et al.
Publicado: (2020)

New-Onset Uncontrolled Hypertension and Renal Failure in a Young Woman
por: Rainer, Katharine, et al.
Publicado: (2020)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?
por: Doumas, Michael, et al.
Publicado: (2020)

Con: Renal denervation for all resistant hypertensive patients: the Emperor's new clothes
por: Persu, Alexandre, et al.
Publicado: (2014)

Renal denervation – can we press the “ON” button again?
por: Kądziela, Jacek, et al.
Publicado: (2018)

Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
por: Lessey, Gayatri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ns4fhutgkf5fude3gnckn9dp0i